The FDA has approved two gene therapies for sickle cell disease, which use a patient’s own stem cells to prevent red blood cells from sickling, but come with risks and are expensive.
The FDA has approved two gene therapies for sickle cell disease, which use a patient’s own stem cells to prevent red blood cells from sickling, but come with risks and are expensive.
We'll send a verification code to %EMAIL%.
Get the best of The Community Voice directly in your email inbox.
Sending to: